Showing results (111-120 of 248) with videos related to
Sort By:
Pageof 25
Arthritis and Rheumatism|July 9, 2003
Regulation of p53 by macrophage migration inhibitory factor in inflammatory arthritisMichelle Leech, Derek Lacey, Jin Rong Xue, et al.Arthritis & Rheumatology (Hoboken, N.J.)|April 24, 2014
Endogenous myeloperoxidase is a mediator of joint inflammation and damage in experimental arthritisDragana Odobasic, Yuan Yang, Ruth C M Muljadi, et al.Journal of Translational Autoimmunity|September 22, 2025
Regulatory T cell therapy for Sjögren's disease: From pathogenesis to targeted treatmentZhi Feng Sherman Lim, Alberta Y Hoi, Fabien B Vincent, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 20, 2006
Regulation of IL-1 and TNF receptor expression and function by endogenous macrophage migration inhibitory factorMyew-Ling Toh, Daniel Aeberli, Derek Lacey, et al.Journal of Clinical Pharmacology|March 30, 2022
Relationship Between Anifrolumab Pharmacokinetics, Pharmacodynamics, and Efficacy in Patients With Moderate to Severe Systemic Lupus ErythematosusYen Lin Chia, Raj Tummala, Tu H Mai, et al.Lupus Science & Medicine|November 7, 2018
Analysis of urinary macrophage migration inhibitory factor in systemic lupus erythematosusFabien B Vincent, Laura Slavin, Alberta Y Hoi, et al.The Journal of Pharmacology and Experimental Therapeutics|September 6, 2023
Preclinical Evidence for the Glucocorticoid-Sparing Potential of a Dual Toll-Like Receptor 7/8 Inhibitor in Autoimmune DiseasesAnkita Deshmukh, Albertina Pereira, Nicholas Geraci, et al.Lupus Science & Medicine|April 8, 2026
Efficacy and safety of anifrolumab in patients with systemic lupus erythematosus without prior immunosuppressant use: post hoc analysis of phase 3 TULIP-1 and TULIP-2 trialsAndrea Doria, Ronald F van Vollenhoven, Eric F Morand, et al.Arthritis and Rheumatism|April 9, 2005
Reduction of arthritis severity in protease-activated receptor-deficient miceYuan H Yang, Pam Hall, Christopher B Little, et al.Clinical & Translational Immunology|April 19, 2019
Analysis of serum interleukin(IL)-1α, IL-1β and IL-18 in patients with systemic sclerosisEmily Lin, Fabien B Vincent, Joanne Sahhar, et al.Pageof 25